PAPER Cummings J
SEARCH RESULTS
329654 RESULTS
PAPER Ţînţaş ML, Peauger L, Barré A, Papamicaël C, Besson T, Sopkovà-de Oliveira Santos J, Gembus V, Levacher V
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.
RSC Med Chem. 2024 Mar 20;15(3):963-980. Epub 2024 Feb 20 PubMed: 38516603PAPER Mitrovska A, Safari P, Ritter K, Shariati B, Fischer JK
Secure federated learning for Alzheimer's disease detection.
Front Aging Neurosci. 2024;16:1324032. Epub 2024 Mar 7 PubMed: 38515517PAPER Li X, Bedlack R
Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis.
Expert Opin Emerg Drugs. 2024 Mar 22;:1-10. PubMed: 38516735PAPER Jangra J, Bajad NG, Singh R, Kumar A, Singh SK
Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of Alzheimer's disease.
Mol Divers. 2024 Mar 22; PubMed: 38517648PAPER Sauvé F, Kacimi L, Prévot V
The hypothalamic-pituitary-gonadal axis and the enigma of Alzheimer disease sex differences.
Nat Rev Endocrinol. 2024 Mar 21; PubMed: 38514817PAPER Van Etten EJ, Bharadwaj PK, Grilli MD, Raichlen DA, Hishaw GA, Huentelman MJ, Trouard TP, Alexander GE
Impact of age and apolipoprotein E ε4 status on regional white matter hyperintensity volume and cognition in healthy aging.
J Int Neuropsychol Soc. 2024 Mar 22;:1-11. PubMed: 38515367PAPER Dong Q, Cui Z, Wu X, Li L, Lu F, Liu F
Natural flavonoid hesperetin blocks amyloid β-protein fibrillogenesis, depolymerizes preformed fibrils and alleviates cytotoxicity caused by amyloids.
Food Funct. 2024 Mar 22; PubMed: 38517352PAPER Ding H, Wang B, Hamel AP, Karjadi C, Ang TF, Au R, Lin H
Exploring cognitive progression subtypes in the Framingham Heart Study.
Alzheimers Dement (Amst). 2024;16(1):e12574. Epub 2024 Mar 21 PubMed: 38515438PAPER Varshavskaya KB, Petrushanko IY, Mitkevich VA, Barykin EP, Makarov AA
Post-translational modifications of beta-amyloid alter its transport in the blood-brain barrier in vitro model.
Front Mol Neurosci. 2024;17:1362581. Epub 2024 Mar 7 PubMed: 38516041PAPER Shan X, Lu Y, Luo Z, Zhao X, Pang M, Yin H, Guo X, Zhou H, Zhang J, Huang J, Shi Y, Lou J, Luo L, You J
A Long-Acting Lyotropic Liquid Crystalline Implant Promotes the Drainage of Macromolecules by Brain-Related Lymphatic System in Treating Aged Alzheimer's Disease.
ACS Nano. 2024 Mar 22; PubMed: 38517764PAPER Saha O, Melo de Farias AR, Pelletier A, Siedlecki-Wullich D, Landeira BS, Gadaut J, Carrier A, Vreulx AC, Guyot K, Shen Y, Bonnefond A, Amouyel P, Tcw J, Kilinc D, Queiroz CM, Delahaye F, Lambert JC, Costa MR
The Alzheimer's disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons.
Mol Psychiatry. 2024 Mar 22; PubMed: 38514804PAPER Mattke S, Jun H, Chu S, Hanson M
Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
J Alzheimers Dis. 2024 Mar 22; PubMed: 38517787PAPER Upadhyaya P, Ling Y, Chen L, Kim Y, Jiang X
Inferring Personalized Treatment Effect of Antihypertensives on Alzheimer's Disease Using Deep Learning.
IEEE Int Conf Healthc Inform. 2023 Jun;2023:49-57. Epub 2023 Dec 11 PubMed: 38516035PAPER Dey P, Biswas P
Effect of caffeine on the aggregation of amyloid-β-A 3D RISM study.
J Chem Phys. 2024 Mar 28;160(12) PubMed: 38516974Current Filters
- Date Range : All x